Search clinical trials for: KRAS-mutant
Total 9 results
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Chugai Pharma USAActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumors for Phase Ib | Pancreatic Cancer for Phase II | Colorectal Cancer for Phase IIUnited States, Canada, Australia, Belgium, Germany, Netherlands, Spain
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Asana BioSciencesCompletedCancer | Neoplasm Metastasis | Pancreatic Cancer | Metastatic Cancer | Metastatic Lung Cancer | Pancreas Adenocarcinoma | Metastatic Melanoma | Colon Cancer | Colonic Neoplasms | Pancreas Cancer | Non Small Cell Lung Cancer Metastatic | Neoplasm | Pancreas Neoplasm | Metastatic Pancreatic Cancer | Metastatic Colon Cancer and other conditionsUnited States
-
Immunovative Therapies, Ltd.CompletedColorectal Cancer MetastaticUnited States
-
Oncolytics BiotechMontefiore Medical CenterCompletedKRAS Mutant Metastatic Colorectal CancerUnited States
-
Infinity Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States